Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
2.480
+0.010 (0.40%)
At close: Dec 5, 2025, 4:00 PM EST
2.570
+0.090 (3.63%)
After-hours: Dec 5, 2025, 6:51 PM EST
CMMB's stock price has decreased by -62.87% in the past year and price targets may not have had time to catch up.

Chemomab Therapeutics Analyst Ratings

Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$26.50
Upside
+968.55%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
Oppenheimer
Oppenheimer
Buy
Maintains
$10$25
Buy Maintains $10$25 +908.06% Aug 27, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$44$40
Buy Maintains $44$40 +1,512.90% May 16, 2025
Maxim Group
Maxim Group
Strong Buy
Maintains
$16$28
Strong Buy Maintains $16$28 +1,029.03% Feb 20, 2025
Oppenheimer
Oppenheimer
Buy
Reiterates
$52$44
Buy Reiterates $52$44 +1,674.19% Nov 15, 2024
Maxim Group
Maxim Group
Strong Buy
Initiates
$16
Strong Buy Initiates $16 +545.16% May 13, 2024
Oppenheimer
Oppenheimer
Buy
Upgrades
$24
Buy Upgrades $24 +867.74% May 6, 2024
Oppenheimer
Oppenheimer
Hold
Maintains
n/a
Hold Maintains n/a n/a Mar 8, 2024
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,029.03% Dec 19, 2023
Roth MKM
Roth MKM
Strong Buy
Initiates
$28
Strong Buy Initiates $28 +1,029.03% Oct 6, 2023
Oppenheimer
Oppenheimer
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Jun 7, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$48$28
Buy Maintains $48$28 +1,029.03% Apr 18, 2023
Oppenheimer
Oppenheimer
Buy
Maintains
$120$80
Buy Maintains $120$80 +3,125.81% Mar 10, 2022
Aegis Capital
Aegis Capital
Strong Buy
Initiates
$120
Strong Buy Initiates $120 +4,738.71% Dec 7, 2021
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$180
Buy Initiates $180 +7,158.06% May 26, 2021
Oppenheimer
Oppenheimer
Buy
Initiates
$168
Buy Initiates $168 +6,674.19% May 7, 2021